ask="0.330"
ask_size="18800"
average_daily_volume="1590100"
bid="0.295"
bid_size="10000"
book_value="0.168"
change="+0.000"
change_from_200_day_moving_average="-0.062"
change_from_50_day_moving_average="-0.020"
change_from_52_week_high="-0.843"
change_From_52_week_low="0.007"
change_in_percent="+0.169%"
close="0.297"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.204"
ebitda="-41.64M"
eps_estimate_current_year="-0.130"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.301"
high_52_weeks="1.140"
last_trade_date="1/10/2017"
last_trade_price="0.297"
last_trade_size="360"
last_trade_time="4:00pm"
low="0.296"
low_52_weeks="0.290"
market_capitalization="76.37M"
moving_average_200_day="0.359"
moving_average_50_day="0.317"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.250"
open="0.298"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-17.219%"
percent_change_from_50_day_moving_average="-6.211%"
percent_change_from_52_week_high="-73.947%"
percent_change_from_52_week_low="+2.414%"
previous_close="0.296"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.765"
price_per_sales="1.400"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.570"
stock_exchange="NCM"
symbol="PPHM"
volume="1350653"
weeks_range_52="0.290 - 1.140"
